FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2889472982> ?p ?o ?g. }

• W2889472982 endingPage "978" @default.
• W2889472982 startingPage "972" @default.
• W2889472982 abstract "Accurate predictors of locally advanced and recurrence disease in patients with gastrointestinal cancer are currently lacking. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) have emerged as possible markers for predicting recurrence in these patients. In this study, we sought to evaluate the utility of NLR and PLR in predicting the presence of regional nodal disease, metastasis and systemic recurrence in patients with gastrointestinal malignancies.We queried a comprehensive gastrointestinal oncology database to identify patients who had undergone surgery for a GI malignancy. NLR and PLR values were determined via a complete blood count (CBC). In patients treated with neoadjuvant therapy (NT) the NLR and PLR were calculated from CBCs before and after NT and in patients proceeding to surgery within 2 weeks pre-operatively. The associations between NLR and PLR and the clinicopathologic parameters (sex, age, tumor size, differentiation, positive lymph nodes, and metastatic disease) were assessed via χ2 or Fisher's exact tests where appropriate. All the tests were two-sided, and P<0.05 was considered statistically significant.We identified 116 patients diagnosed with gastrointestinal malignancies. There were 76 (65.5%) males and 40 (34.5%) females with an average age of 69.4±10.7 years. The mean follow up was 14.1±15.5 months. We identified 49 (42.2%) esophageal, 34 (29.3%) pancreatic, 14 (12.1%) colorectal, 13 (11.2%) gastric, and 6 (5.2%) biliary cancers. There were 36 (31.0%) patients with node negative disease, 52 (44.8%) with node positive and 28 (24.2%) with metastatic disease at surgery. Of the metastatic patients 4 (3.4%) were found at staging laparoscopy and 24 (20.6%) were diagnosed pre-operatively. The median NLR for LN- patient's was 1.78 (0.23-8.2) and for LN+ and metastatic patients was 4.69 (2.27-36), P<0.001. The median PLR for LN- patient's was 123.03 (14-257.69) and for LN+ and metastatic patients was 212.42 (105.45-2,185.18), P<0.001. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for a NLR >2.25 was 98.8%, 72.2%, 89%, and 96% respectively. The sensitivity, specificity, PPV, and NPV for PLR >140 was 95%, 78%, 90%, and 88% respectively. Utilizing both NLR and PLR the sensitivity, specificity, PPV and NPV was increased.Elevation of NLR and PLR can be used to help identify patients with advanced disease GI malignancies and recurrences after surgery. Additionally, failure of normalization of NLR and PLR 3-month post-surgical resection may indicate early recurrence or persistent disease. Individually, NLR has a higher sensitivity and negative predictive value while PLR has a higher specificity and positive predictive value for distinguishing metastatic disease and node positivity. The combination of NLR and PLR has the highest accuracy of predicting advanced disease among all gastrointestinal malignancies." @default.
• W2889472982 created "2018-09-07" @default.
• W2889472982 creator A5015716788 @default.
• W2889472982 creator A5029626497 @default.
• W2889472982 creator A5052495476 @default.
• W2889472982 creator A5088425545 @default.
• W2889472982 date "2018-10-01" @default.
• W2889472982 modified "2023-10-16" @default.
• W2889472982 title "The accuracy of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as a marker for gastrointestinal malignancies" @default.
• W2889472982 cites W1012805360 @default.
• W2889472982 cites W1035770698 @default.
• W2889472982 cites W1574011925 @default.
• W2889472982 cites W1913791506 @default.
• W2889472982 cites W1942806811 @default.
• W2889472982 cites W1965037168 @default.
• W2889472982 cites W1970844776 @default.
• W2889472982 cites W1975126186 @default.
• W2889472982 cites W1977222310 @default.
• W2889472982 cites W1980358318 @default.
• W2889472982 cites W1988082986 @default.
• W2889472982 cites W1992699637 @default.
• W2889472982 cites W201458761 @default.
• W2889472982 cites W2015215068 @default.
• W2889472982 cites W2022403559 @default.
• W2889472982 cites W2024210813 @default.
• W2889472982 cites W2033957926 @default.
• W2889472982 cites W2034267351 @default.
• W2889472982 cites W2043317488 @default.
• W2889472982 cites W2046445099 @default.
• W2889472982 cites W2047945295 @default.
• W2889472982 cites W2048083571 @default.
• W2889472982 cites W2068031166 @default.
• W2889472982 cites W2070199947 @default.
• W2889472982 cites W2073615039 @default.
• W2889472982 cites W2108888241 @default.
• W2889472982 cites W2118278569 @default.
• W2889472982 cites W2144692208 @default.
• W2889472982 cites W2145592472 @default.
• W2889472982 cites W2147212677 @default.
• W2889472982 cites W2170552969 @default.
• W2889472982 cites W2195008195 @default.
• W2889472982 cites W2297566460 @default.
• W2889472982 cites W2320895539 @default.
• W2889472982 cites W2341684918 @default.
• W2889472982 cites W2399442225 @default.
• W2889472982 cites W2400116502 @default.
• W2889472982 cites W2406315264 @default.
• W2889472982 cites W2411637008 @default.
• W2889472982 doi "https://doi.org/10.21037/jgo.2018.08.05" @default.
• W2889472982 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6219984" @default.
• W2889472982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30505600" @default.
• W2889472982 hasPublicationYear "2018" @default.
• W2889472982 type Work @default.
• W2889472982 sameAs 2889472982 @default.
• W2889472982 citedByCount "19" @default.
• W2889472982 countsByYear W28894729822019 @default.
• W2889472982 countsByYear W28894729822020 @default.
• W2889472982 countsByYear W28894729822021 @default.
• W2889472982 countsByYear W28894729822022 @default.
• W2889472982 countsByYear W28894729822023 @default.
• W2889472982 crossrefType "journal-article" @default.
• W2889472982 hasAuthorship W2889472982A5015716788 @default.
• W2889472982 hasAuthorship W2889472982A5029626497 @default.
• W2889472982 hasAuthorship W2889472982A5052495476 @default.
• W2889472982 hasAuthorship W2889472982A5088425545 @default.
• W2889472982 hasBestOaLocation W28894729822 @default.
• W2889472982 hasConcept C121608353 @default.
• W2889472982 hasConcept C126322002 @default.
• W2889472982 hasConcept C143998085 @default.
• W2889472982 hasConcept C2777761686 @default.
• W2889472982 hasConcept C2778963024 @default.
• W2889472982 hasConcept C2779134260 @default.
• W2889472982 hasConcept C2779399171 @default.
• W2889472982 hasConcept C2780849966 @default.
• W2889472982 hasConcept C526805850 @default.
• W2889472982 hasConcept C542804219 @default.
• W2889472982 hasConcept C71924100 @default.
• W2889472982 hasConcept C90924648 @default.
• W2889472982 hasConceptScore W2889472982C121608353 @default.
• W2889472982 hasConceptScore W2889472982C126322002 @default.
• W2889472982 hasConceptScore W2889472982C143998085 @default.
• W2889472982 hasConceptScore W2889472982C2777761686 @default.
• W2889472982 hasConceptScore W2889472982C2778963024 @default.
• W2889472982 hasConceptScore W2889472982C2779134260 @default.
• W2889472982 hasConceptScore W2889472982C2779399171 @default.
• W2889472982 hasConceptScore W2889472982C2780849966 @default.
• W2889472982 hasConceptScore W2889472982C526805850 @default.
• W2889472982 hasConceptScore W2889472982C542804219 @default.
• W2889472982 hasConceptScore W2889472982C71924100 @default.
• W2889472982 hasConceptScore W2889472982C90924648 @default.
• W2889472982 hasIssue "5" @default.
• W2889472982 hasLocation W28894729821 @default.
• W2889472982 hasLocation W28894729822 @default.
• W2889472982 hasLocation W28894729823 @default.
• W2889472982 hasLocation W28894729824 @default.
• W2889472982 hasLocation W28894729825 @default.
• W2889472982 hasOpenAccess W2889472982 @default.
• W2889472982 hasPrimaryLocation W28894729821 @default.

• next